Aleksandra Pietowska-Podlecka

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Impaired temporal processing in multiple sclerosis.

Impaired temporal processing in multiple sclerosis.

Journal: Brain and cognition
Published: September 16, 2025

Evaluation of the humoral response during ocrelizumab therapy in multiple sclerosis - an observational study.

Evaluation of the humoral response during ocrelizumab therapy in multiple sclerosis - an observational study.

Journal: Neurologia i neurochirurgia polska
Published: August 28, 2025

Selected aspects of epidemiology of multiple sclerosis in Poland: a multicenter pilot study.

Selected aspects of epidemiology of multiple sclerosis in Poland: a multicenter pilot study.

Journal: Neurologia i neurochirurgia polska
Published: July 21, 2025

Long-term progressive multifocal leukoencephalopathy risk stratification in multiple sclerosis patients treated with natalizumab with positive John Cunningham virus index.

Long-term progressive multifocal leukoencephalopathy risk stratification in multiple sclerosis patients treated with natalizumab with positive John Cunningham virus index.

Journal: Neurologia i neurochirurgia polska
Published: May 09, 2025

Improving Quality of Life in Polish patients with multiple sclerosis: a multicentre analysis.

Improving Quality of Life in Polish patients with multiple sclerosis: a multicentre analysis.

Journal: Neurologia i neurochirurgia polska
Published: February 26, 2025

Update on diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - recommendations of Section of Multiple Sclerosis and Neuroimmunology of Polish Neurological Society.

Update on diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - recommendations of Section of Multiple Sclerosis and Neuroimmunology of Polish Neurological Society.

Journal: Neurologia i neurochirurgia polska
Published: May 31, 2024

Patterns of cerebral damage in multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders-major differences revealed by non-conventional imaging.

Patterns of cerebral damage in multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders-major differences revealed by non-conventional imaging.

Journal: Brain communications
Published: February 16, 2024

Analysis of seroconversion following COVID-19 vaccination among multiple sclerosis patients treated with disease-modifying therapies in Poland.

Analysis of seroconversion following COVID-19 vaccination among multiple sclerosis patients treated with disease-modifying therapies in Poland.

Journal: Neurologia i neurochirurgia polska
Published: July 08, 2023

Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study.

Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study.

Journal: Neurologia i neurochirurgia polska
Published: June 12, 2022

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.

Journal: Vaccines
Published: April 11, 2022

Serum metabolic profiles and metal levels of patients with multiple sclerosis and patients with neuromyelitis optica spectrum disorders - NMR spectroscopy and ICP-MS studies.

Serum metabolic profiles and metal levels of patients with multiple sclerosis and patients with neuromyelitis optica spectrum disorders - NMR spectroscopy and ICP-MS studies.

Journal: Multiple sclerosis and related disorders
Published: December 22, 2021

COVID-19 in neuromyelitis optica spectrum disorder patients in Poland.

COVID-19 in neuromyelitis optica spectrum disorder patients in Poland.

Journal: Multiple sclerosis and related disorders
Published: October 29, 2021
Showing 1-12 of 28

Last Updated: 09/26/2026